The challenges of maintaining momentum in CF drug development and approval - Commentary.
Journal of Cystic Fibrosis, USA; Medical University of South Carolina, USA. Electronic address: flumepa@musc.edu.
Patrick A
PA
Flume
Journal of Cystic Fibrosis, USA; Case Western Reserve University School of Medicine, USA.
Donald R
DR
VanDevanter
D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000502:physiology; D017277:Drug Approval; D000076722:Drug Development; D055808:Drug Discovery / Q000379:methods / Q000639:trends; D006801:Humans; D054539:Medication Therapy Management / Q000639:trends*; D058990:Molecular Targeted Therapy / Q000379:methods; D010346:Patient Care Management / Q000379:methods / Q000639:trends; D016896:Treatment Outcome
C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator